Arrotex bolsters pharmacy offering

business acquisitions handshake
Following the merger of Apotex and Arrow, the combined Arrotex entity now has a considerable portfolio of respiratory medicines – including two new products Arrotex Pharmaceuticals has announced a strategic partnership with Boehringer Ingelheim for the exclusive Australian reseller rights to respiratory products Spiriva (tiotropium 18 micrograms powder for inhalation) and Spiriva HandiHaler, both used

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous World news wrapup: 6 February 2020
Next Delving into the opioid epidemic